The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma
Version of Record online: 6 APR 2005
Copyright © 2005 American Cancer Society
Volume 103, Issue 10, pages 2053–2059, 15 May 2005
How to Cite
Nguyen, P. L., Whittington, R., Koo, S., Schultz, D., Cote, K. B., Loffredo, M., McMahon, E., Renshaw, A. A., Tomaszewski, J. E. and D'Amico, A. V. (2005), The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer, 103: 2053–2059. doi: 10.1002/cncr.21050
- Issue online: 28 APR 2005
- Version of Record online: 6 APR 2005
- Manuscript Accepted: 12 JAN 2005
- Manuscript Revised: 3 JAN 2005
- Manuscript Received: 9 SEP 2004
- Clinical Research Fellowship Program at Harvard Medical School offered by the Doris Duke Charitable Foundation
- Harvard PASTEUR Program
- Harvard Office of Enrichment Programs
- 3The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 1998; 42: S97., , , et al.
- 7Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol. 2003; 10: 1891–1898., , , et al.
- 8How long can radical prostatectomy (RP) safely be delayed? CPDR's experiences from 3324 cases. J Urol. 171(Suppl 4): 312., , , et al.
- 9American Joint Committee on Cancer. AJCC Cancer Staging Manual. 4th ed. Philadelphia: Lippincott–Raven, 1992.
- 12American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Rad Onc Biol Phys. 1997; 37: 1035–1041.